Evaluation of the efficacy and safety of telbivudin in preventing mother-to-infant HBV transmission

Chinese Pharmaceutical Journal

Volumn 47, Issue 11, 2012, Pages 855-857

  Peng, Bao An ^a   Zhao, Yi ^a   Yang, Xiao Fu ^a   Miao, Min Fang ^a   Zhu, Lin Hua ^a   Yu, He Yong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatitis B virus; Mother to infant transmission; Safety; Telbivudine; Third trimester

Indexed keywords

DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; TELBIVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; BIRTH; CONTROLLED STUDY; DELIVERY; DRUG SAFETY; FEMALE; HEPATITIS B VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; PREGNANT WOMAN; THIRD TRIMESTER PREGNANCY; VERTICAL TRANSMISSION;

EID: 84866462758     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. HANG R H, ZHAO W, Y M M, et al. The comparison of different methods for blocking between mothers and infants transmission of hepatitis B virus [J]. Chin J Obstet Gynecol, 2006, 41(12): 837-838.
2. QIU S X, WU S M, JIANG P R, et al. The relationship of serum hepatitis B virus DNA load in HBsAg positive pregnant women to the intrauterine infection of newborns [J]. Shanghai J Prev Med, 2005, 17(9):428-429.
3. HAN Z H, ZHONG L H, WANG J, et al. The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns [J]. Chin J Inter Med, 2007, 46(5):376-378.
4. LIN J, LIAO S, GUO G Z, et al. Significance of hepatitis B virus DNA quantity in transmission between mathers and infants [J]. Chin J Pediatr, 2002, 40(2):84-87.
5. WAN M S. Attention to pregnancy safety of nucleotide analogues [J]. Chin J Exp Clin Infect Dis, 2008, 2(3): 127-130.
6. ZHANG Y F, HU Y H. Efficacy and safety of telbivudin in preventing mother-to-infant HBV transmission [J]. Adverse Drug React, 2010, 12(3):157-159.
7. Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B [J]. Chin J Infect Dis, 2005, 23(6): 421-431.